Evaluation in mice of the immunogenicity and protective efficacy of a tetravalent subunit vaccine candidate against dengue virus
Laura Lazo(Centro de Ingeniería Genética y Biotecnología), Lisset Hermida Cruz(Centro de Ingeniería Genética y Biotecnología), Edith Suzarte(Centro de Ingeniería Genética y Biotecnología), Ernesto Marcos(Centro de Ingeniería Genética y Biotecnología), Iris Valdés(Centro de Ingeniería Genética y Biotecnología), Gerardo Guillén(Hunan City University), Yaremis Romero(Centro de Ingeniería Genética y Biotecnología), Mayling Álvarez(Instituto de Medicina Tropical “Pedro Kourí”), Lázaro Gil(Centro de Ingeniería Genética y Biotecnología), María Guadalupe Guzmán(Instituto de Medicina Tropical “Pedro Kourí”), Alienys Izquierdo(Instituto de Medicina Tropical “Pedro Kourí”)
Cited by 20
Related Papers
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review
|Frontiers in Endocrinology|2020|134